GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
29 hedge funds and large institutions have $752K invested in Aevi Genomic Medicine Inc in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$138K | |
| 2 | +$90.9K | |
| 3 | +$10K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$6K |
| 5 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
+$2K |
Top Sellers
| 1 | -$44K | |
| 2 | -$39.3K | |
| 3 | -$28.1K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$25K |
| 5 |
BlackRock
New York
|
-$15.5K |